AWP
Ascent Wealth Partners’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-6,279
| Closed | -$831K | – | 120 |
|
|
2019
Q3 | $831K | Buy |
6,279
+200
| +3% | +$26.5K | 0.25% | 66 |
|
|
2019
Q2 | $863K | Buy |
6,079
+260
| +4% | +$36.9K | 0.27% | 67 |
|
|
2019
Q1 | $845K | Buy |
5,819
+451
| +8% | +$65.5K | 0.28% | 66 |
|
|
2018
Q4 | $608K | Sell |
5,368
-40
| -0.7% | -$4.53K | 0.24% | 74 |
|
|
2018
Q3 | $728K | Buy |
5,408
+111
| +2% | +$14.9K | 0.23% | 81 |
|
|
2018
Q2 | $594K | Buy |
5,297
+29
| +0.6% | +$3.25K | 0.21% | 82 |
|
|
2018
Q1 | $562K | Buy |
5,268
+30
| +0.6% | +$3.2K | 0.2% | 84 |
|
|
2017
Q4 | $573K | Buy |
5,238
+8
| +0.2% | +$875 | 0.21% | 83 |
|
|
2017
Q3 | $565K | Buy |
5,230
+160
| +3% | +$17.3K | 0.23% | 79 |
|
|
2017
Q2 | $513K | Sell |
5,070
-5
| -0.1% | -$506 | 0.22% | 82 |
|
|
2017
Q1 | $456K | Buy |
5,075
+25
| +0.5% | +$2.25K | 0.21% | 82 |
|
|
2016
Q4 | $385K | Buy |
+5,050
| New | +$385K | 0.19% | 88 |
|